HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

Numotion Agrees to a $7 Million Medicaid Settlement

February 9, 2023 by David Kopf

National mobility provider Numotion has reached an agreement with the United States Attorney’s Office in the Eastern District of Kentucky to settle a lawsuit stemming from claims related to reimbursement payments for mobility equipment. 

Under the agreement, which the Office of Inspector General for Health and Human Services also signed, Numotion will pay $7 million dollars to resolve allegations that Numotion said focused mainly on “a complicated set of Medicaid billing regulations” that the company believed it had interpreted correctly.

In a public statement, Numotion underscored that it has cooperated fully with the U.S. Attorney for the Eastern District of Kentucky over the course of the matter.

“Numotion is committed to cooperating with external investigations as well as fulfilling our responsibility to submit self-disclosures where appropriate,” said Mike Swinford, Numotion’s CEO. “We are proud of the work we do helping our customers lead active and independent lives, and we are dedicated to supporting them with medically necessary products and services. Putting this matter behind us ensures we can direct all our attention on our mission.” 

The settlement was reached without any admission of liability, and there was no indication that any of the equipment that Numotion provided was not reasonable and medically necessary. 

As part of this settlement, Numotion also entered into a Corporate Integrity Agreement with HHS OIG, under which the company will implement specific corporate compliance obligations that complement its existing compliance program, which it said is “extensive and robust.” 

Related Articles Read More >

Sleep Awareness Week Prioritizes the Importance of Quality Sleep for All
The National Sleep Foundation’s latest report is a sobering reminder of the importance of quality sleep.
Medtrade 2026: Rehasense Wins Providers’ Choice Gold in New Product Pavilion
Attendees voted for their favorite new launches in Phoenix last week.
Quipt Acquisition Clears Final Court Approval
The transition from publicly held to privately held company is expected to finish this month.
A Human Factors Scorecard: 3 Medtrade Products That Got It Right
Highlighting three expo hall standouts in Phoenix.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe